A Royan Institute Cell Therapy Achievement Featured on a Global Specialized Platform

MedPath, an international platform specializing in medical information, clinical trials, and health technologies, has published a report highlighting the development and approval of WhartoCell, a cell therapy product developed by Royan Institute.
source: en.isna.ir